Phase 2 Clinical Trials

490 trials are at Phase 2 in the index.

Trials (490)

Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2 · Jules Bordet Institute
Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML Phase 2 · Institute of Hematology & Blood Diseases Hospital, China
Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC Phase 2 · Hubei Cancer Hospital
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study) Phase 2 · Peking University Third Hospital
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial Phase 2 · Universitaire Ziekenhuizen KU Leuven
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer Phase 2 · Gynecologic Oncology Group
Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia Phase 2 · Dana-Farber Cancer Institute
NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) Phase 2 · NFlection Therapeutics, Inc.
Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma Phase 2 · Institut Curie
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) Phase 2 · University College, London
Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts Phase 2 · Sheikh Zayed Medical College
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide Phase 2 · M.D. Anderson Cancer Center
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Phase 2 · Alliance for Clinical Trials in Oncology
Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC Phase 2 · Tang-Du Hospital
FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine Phase 2 · Federation Francophone de Cancerologie Digestive
A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer Phase 2 · Eli Lilly and Company
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma Phase 2 · Hoffmann-La Roche
Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer Phase 2 · Peking University Cancer Hospital & Institute
Hypofractionated Radiotherapy for Soft Tissue Sarcomas Phase 2 · University of Wisconsin, Madison
mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma Phase 2 · Asan Medical Center
A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer Phase 2 · Jin Ying
Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer Phase 2 · Tongji University
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors Phase 2 · Amgen
Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin Phase 2 · Uppsala University Hospital
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors Phase 2 · Hoffmann-La Roche
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer Phase 2 · Mayo Clinic
Tanespimycin in Treating Patients With Stage III-IV Melanoma Phase 2 · National Cancer Institute (NCI)
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. Phase 2 · St. Jude Children's Research Hospital
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer Phase 2 · Pfizer
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts Phase 2 · ViroXis Corporation
Radiation Free Chemotherapy for Early Hodgkin Lymphoma Phase 2 · Medical University of Gdansk
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma Phase 2 · University of Michigan Rogel Cancer Center
MG4101 for Refractory or Relapsed AML Phase 2 · Seoul National University Hospital
TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer Phase 2 · Memorial Sloan Kettering Cancer Center
Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix Phase 2 · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer Phase 2 · European Organisation for Research and Treatment of Cancer - EORTC
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. Phase 2 · Treos Bio Limited
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study Phase 2 · Maastricht University Medical Center
Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia Phase 2 · Karolinska University Hospital
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma Phase 2 · The First Affiliated Hospital of Xiamen University
Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation Phase 2 · The Catholic University of Korea
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC Phase 2 · Yale University
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Phase 2 · Apexigen America, Inc.
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder Phase 2 · NYU Langone Health
Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms Phase 2 · National Center for Complementary and Integrative Health (NCCIH)
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Phase 2 · Sun Yat-sen University
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver Phase 2 · M.D. Anderson Cancer Center
Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC Phase 2 · Tianjin Medical University Cancer Institute and Hospital
Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment. Phase 2 · Kidney Cancer Research Bureau
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer Phase 2 · National Cancer Institute (NCI)

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.